About 113,000 results
Open links in new tab
FDA grants accelerated approval to fam-trastuzumab deruxtecan …
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the …
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the …
Enhertu approved in the US as first tumour-agnostic HER2 …
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 …
Enhertu Approved for Any HER2-Positive Solid Cancer - NCI
ENHERTU® Granted Breakthrough Therapy Designation in U.S.
Enhertu approved in the US for patients with HER2 ... - AstraZeneca
Enhertu Improves Survival for Metastatic “HER2-Low” Breast Cancer